Alumend is a privately held biotech firm developing innovative medical products based on a platform tissue bonding technology. Products will target the tissue adhesive and sealant industry, dermatology, neurology and vascular surgery. This technology will also be exploited for local drug delivery and bulking/reconstructive surgery applications. Alumend was previously known as PhotoBioMed.